Adalimumab-bwwd 40 mg/.4mL
adalimumab-bwwd · SOLUTION · Cordavis Limited
No Recall History
Plain English
Adalimumab-bwwd is a solution containing adalimumab-bwwd at 40 mg/.4mL, taken subcutaneous. Manufactured by Cordavis Limited.
Key Facts
- Brand Name
- Adalimumab-bwwd
- Generic Name
- adalimumab-bwwd
- NDC Code (Product)
83457-186- Manufacturer
- Cordavis Limited
- Strength
- 40 mg/.4mL
- Dosage Form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761059
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 12/12/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Adalimumab-bwwd used for?
Adalimumab-bwwd contains adalimumab-bwwd. It is a solution taken subcutaneous. Consult your doctor for specific uses.
Is Adalimumab-bwwd a controlled substance?
Adalimumab-bwwd is not classified as a controlled substance by the DEA.
What is the generic name for Adalimumab-bwwd?
The generic name for Adalimumab-bwwd is adalimumab-bwwd. There are 8 other brand versions of adalimumab-bwwd.
What is the NDC code for Adalimumab-bwwd 40 mg/.4mL?
The NDC (National Drug Code) for Adalimumab-bwwd 40 mg/.4mL is 83457-186, listed by Cordavis Limited.